Myocardial contrast echocardiography in acute coronary syndromes

Current Opinion in Cardiology

Volumn 17, Issue 5, 2002, Pages 455-463

  Ward, R Parker ^a   Lang, Roberto M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECHO CONTRAST MEDIUM; FLUOROCARBON; FS 069; NC 100100; OCTAFLUOROPROPANE; PERFLUOROOCTYL BROMIDE; PERFLUTREN; SHU 508; SONOVUE; SULFUR HEXAFLUORIDE;

ACUTE HEART INFARCTION; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HUMAN; PRIORITY JOURNAL; REVIEW;

ANGINA PECTORIS; ECHOCARDIOGRAPHY; GRAFT OCCLUSION, VASCULAR; HUMANS; MICROCIRCULATION; MICROSPHERES; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA;

EID: 0036753546     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200209000-00003     Document Type: Review

References (52)

1. Cohen JL, Cheirif J, Segar DS, et al.: Improved left ventricular endocardial border delineation and opacification with Optison (FS069), a new echocardiographic contrast agent. Results of a phase III multicenter trial. J Am Coll Cardiol 1998, 32:746-752.
2. Ikonomidis I, Holmes E, Narbuvold H, et al.: Assessment of left ventricular wall motion and delineation of the endocardial border after intravenous injection of infoson during dobutamine stress echocardiography. Coron Artery Dis 1998, 9:567-576.
3. Grayburn PA, Weiss JL, Hack TC, et al.: Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. J Am Coll Cardiol 1998, 32:230-236.
4. Spencer KT, Bednarz J, Mor-Avi V, et al.: The role of echocardiographic harmonic imaging and contrast enhancement for improvement of endocardial border delineation. J Am Soc Echocardiogr 2000, 13:131-138.
5. Wei K: Detection and quantification of coronary stenosis severity with myocardial contrast echocardiography. Prog Cardiovasc Dis 2001, 44(2):81-100.
6. Kaul S: Myocardial contrast echocardiography. Prog Cardiovasc Dis 2001, 44(1):1-11.
7. Le De, Jayaweera AR, Wei K, et al.: Changes in myocardial blood volume over a wide range of coronary driving pressures: Role of capillaries in auto regulation [abstract]. J Am Coll Cardiol 2000, 35:546A.
8. Iwanaga S, Ewing SG, Husseini WK, et al.: Changes in contractility and afterload have only slight effects on subendocardial systolic flow impediment. Am J Physiol 1995, 269:H1202-H1212.
9. Kaul S: Myocardial contrast echocardiography. Curr Prob Cardiol 1997, 22:549-640.
10. Reimer KA, Jennings RB: The "wave front phenomenon" of myocardial ischemic cell death, II: Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral blood flow. Lab Invest 1979, 40:633-644.
11. Schaper W, Frenzel H, Hort W: Experimental coronary artery occlusion: Measurement of infarct size. Basic Res Cardiol 1979, 74:46-53.
12. Kloner RA, Rude RE, Carsion N, et al.: Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: Which comes first? Circulation 1980, 62:945-952.
13. Johnson WB, Malone SA, Pantely GA, et al.: No reflow and extent of infarction during maximal vasodilation in the porcine heart. Circulation 1988, 78:462-472.
14. Skyba DM, Jayaweera AR, Goodman NC, et al.: Quantification of myocardial perfusion with myocardial contrast echocardiography during left atrial injection of contrast. Implications for venous injection. Circulation 1994, 90:1513-1521.
15. Keller MW, Segal SS, Kaul S, et al.: The behavior of sonicated albumin microbubbles within the microcirculation: A basis for their use during myocardial contrast echocardiography. Circ Res 1989, 65:458-467.
16. Skyba DM, Camarano G, Goodman NC, et al.: Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS=069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol 1996, 28:1292-1300.
17. Linder JR, Firschke C, Wei K, et al.: Myocardial perfusion characteristics and hemodynamic profile of MRX-115, a venous echocardiographic contrast agent, during acute myocardial infarction. J Am Soc Echocardiogr 1998, 11:36-46.
18. Schneider M: Characteristics of SonoVue. Echocardiography 1999, 16:743-746.
19. Wei K, Skyba DM, Firschke C, et al.: Interaction between microbubbles and ultrasound. In vitro and in vivo observations. J Am Coll Cardiol 1997, 29:1081-1088.
20. Becher J, Burns PN: Handbook of Contrast Echocardiography: LV Function and Myocardial Perfusion. Berlin: Springer; 2000.
21. Mor-Avi V, Caiani EG, Collins KA, et al.: Combined assessment of myocardial perfusion and regional left ventricular function by analysis of contrast-enhanced power modulation images. Circulation 2001, 104:352-357.
22. Lee TH, Cook EF, Weisberg MG, et al.: Acute chest pain in the emergency room: Identification of low-risk patients. Arch Intern Med 1985, 145:65-69.
23. Short D: The earliest electrocardiographic evidence of myocardial infarction. Br Heart J 1970, 32:6-15.
24. Shivalkar B, Rinkevich D, Kaul S, et al.: Clinical utility of myocardial perfusion imaging in patients presenting with chest pain to the emergency room. Am Coll Cardiol 2002, 39(5):315A.
25. Link A, Sklenar J, Wei K, et al.: Assessment of transmural distribution of myocardial perfusion with contrast echocardiography. Circulation 1998, 98(18):1912-1920.
26. Coggins MP, Sklenar J, Le DE, et al.: Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow. Circulation 2001, 104(20):247.
27. Sakuma T, Hayashi Y, Sum II K, et al.: Prediction of short and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization. J Am Coll Cardiol 1998, 32:890-897.
28. Ito H, Okamura A, Iwakura K, et al.: Myocardial perfusion patterns related to thrombolysis in myocardial infarction grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996, 93:1993-1999.
29. Ito H, Tomooka T, Sakai N, et al.: Lack of myocardial perfusion immediately after successful thrombolysis: A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992, 85:1699-1705.
30. Kondo M, Nakano A, Saito D, et al.: Assessment of microvascular no-reflow phenomenon using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction. J Am Coll Cardiol 1998, 32:898-903.
31. Wu KC, Kim RJ, Bluemke DA, et al.: Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance following acute myocardial infarction and reperfusion. J Am Coll Cardiol 1998, 32:1756-1764.
32. Agati L, Voci P, Bilotta F, et al.: Influence of residual perfusion within the infarct zone on the natural history of left ventricular dysfunction after acute myocardial infarction: A myocardial contrast echocardiographic study. J Am Coll Cardiol 1994, 24:336-342.
33. Agati L, Voci P, Hickle P, et al.: Tissue-type plasminogen activator therapy versus primary coronary angioplasty: Impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction. J Am Coll Cardiol 1998, 31:338-343.
34. Agati L, Funaro S, Bilotta F, et al.: Assessment of no-reflow phenomenon after acute myocardial infarction with harmonic angiography and intravenous pump infusion with levovist: Comparison with intracoronary contrast injection. J Am Soc Echocardiogr 2001, 14:773-781.
35. Ragosta M, Camarano GP, Kaul S, et al.: Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: New insights using myocardial contrast echocardiography. Circulation 1994, 89:2562-2569.
36. Ito H, Maruyama A, Iwakura K, et al.: Clinical implications of the "no reflow" phenomenon: A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996, 93:223-228.
37. Firschke C, Lindner JR, Wei K, et al.: Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of FS-069, a second generation echocardiographic contrast agent. Circulation 1997, 96:959-967.
38. Lindner JR, Firschke C, Wei K, et al.: Myocardial perfusion characteristics and hemodynamic profile of MRX-115, a venous echocardiographic contrast agent, during acute myocardial infarction. J Am Soc Echocardiogr 1998, 11:36-46.
39. Kaul S: Myocardial contrast echocardiography in acute myocardial infarction: Time to test for routine clinical use? Heart 1999, 81(1):2-5.
40. Kamp O, Lepper W, Vanoverschelde JL, et al.: Serial evaluation of perfusion defects in patients with a first acute myocardial infarction referred for primary PTCA using intravenous myocardial contrast echocardiography. Eur Heart J 2001, 22(16):1485-1495.
41. Senior R, Swinburn J, Lahiri A: Enhanced prediction of myocardial viability by contrast echo in dobutamine non-responsive myocardium early after acute myocardial infarction [abstract 1595]. Circulation 2001, 104(17 suppl):II-333.
42. Main ML, Magalski A, Chee NK: Assessment of both contractile reserve and microvascular integrity early after anterior wall myocardial infarction differentiates stunning from necrosis (abstract 3531]. Circulation 2001, 104(17 suppl):II-750.
43. Bax JJ, Wijns W, Cornel JH, et al.: Accuracy of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data. J Am Coll Cardiol 1997, 30(6):1451-1460.
44. Lualdi CJ, Douglas SP: Echocardiography for the assessment of myocardial viability. J Am Soc Echocardiogr 1997, 10:772-781.
45. Chen C, Karanam R, Goldstein D, et al.: Intraoperative contrast echocardiography using selective contrast injection into individual aorto-coronary bypass graft identifies graft failure and predicts perioperative myocardial infarction [abstract 3006]. Circulation 2001, 104(17 suppl):II-636.
46. Mayer S, Grayburn P: Myocardial contrast agents: Recent advances and future directions. Prog Cardiovasc Dis 2001, 44(1):33-44.
47. Jonathan R, Lindner: Assessment of inflammation with contrast ultrasound. Prog Cardiovasc Dis 2001, 44(2):111-120.
48. Lindner JR, Dayton PA, Coggins MP, et al.: Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 2000, 102:531-538.
49. Trubestein G, Engel C, Etzel F, et al.: Thrombolysis by ultrasound. Clin Sci Mol Med 1976, 3(suppl):697S-698S.
50. Porter TR, Feng X: Ultrasound, microbubbles, and thrombolysis. Prog Cardiovasc Dis 2001, 44(2):101-110.
51. Birnbaum Y, Luo H, Nagai T, et al.: Non-invasive in vitro clot dissolution without a thrombolytic drug: Recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of perfluorocarbon-exposed sonicated dextrose albumin microbubbles (PESDA). Circulation 1998, 97:130-134.
52. Nishioka T, Luo H, Fishbein MC, et al.: Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: An in vitro and in vivo study. J Am Coll Cardiol 1997, 30:561-568.